세계의 소아용 관류 시장 : 제품 유형별, 용도별, 최종 사용자별, 지역별

Global Pediatric Perfusion Market, By Product Type, By Application, By End User, By Geography

US $ 4,500 ￦ 6,151,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 9,569,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,671,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 소아용 관류 시장은 2025년 5억 7,530만 달러로 추정되고, 2032년까지 8억 4,250만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 CAGR 5.6%로 성장할 전망입니다.

보고 범위		보고서 세부정보
기준연도	2024년	2025년 시장 규모	5억 7,530만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간: 2025-2032년 CAGR:	5.60%	2032년 가치 예측	8억 4,250만 달러

소아용 관류는 개심술 중 심폐 우회(CPB)를 받는 소아의 순환계를 통해 혈액을 보내는 것입니다. 소아 환자의 해부학적, 생리학적 차이에 대응하기 위한 특수한 장치, 기술, 기능이 필요합니다.

시장 역학:

세계보건기구(WHO)의 추계에 의하면, 선천성 심질환(CHD)은 출생아의 거의 1%에 영향을 미치는 질환입니다. 진단기술의 향상에 의해 CHD의 조기 발견이 가능해져 아동 심장 외과 수술의 진보와 함께 생존율과 치료 성적이 향상되었습니다.

소아용 관류는 인공 심폐 장치를 사용하여 심장 수술 중 소아의 심폐 기능을 지원합니다. 이에 따라 특수한 관류장치에 대한 수요가 높아지고 있습니다.

그러나 소아용 관류 시장은 과제에도 직면하고 있습니다. 소아 심장 수술의 고가의 비용은 특히 종합적인 의료 보험이 적용되지 않는 지역에서는 헬스케어 시스템과 가족에게 큰 경제적 부담이 될 가능성이 있습니다. 소아용 관류 전문의의 부족이 지적되고 있습니다. 다른 과제는 관류 장치 시장을 제한할 수 있는 오프 펌프 외과 수술에 대한 주목이 높아지고 있는 것입니다. 이러한 수술은 심장을 멈추지 않고 행해지기 때문에 인공 심폐 장치를 필요로 하지 않고, 관류 서비스 수요가 감소합니다.

이러한 과제에도 불구하고 소아용 관류 시장은 특히 소형화된 관류 장치의 기술 혁신과 개발에 큰 기회가 존재합니다. 시장의 기업에게 매력적인 기회를 제공하는 것입니다. 또한, 헬스케어의 인프라가 확대되어, 소아 심장 의료에의 액세스가 개선되고 있는 신흥 시장에도 성장의 가능성이 있습니다.

요약: 의료 진보가 계속되는 가운데, 세계의 소아용 관류 시장은 비용, 트레이닝, 기술에 관한 과제에 전략적으로 대처할 수 있으면, 성장하는 좋은 위치에 있습니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 소아용 관류 시장을 상세하게 분석하여 예측 기간(2025-2032년, 2024년을 기준연도로) 시장 규모 및 복합 연간 성장률(CAGR%)을 제공합니다.
• 또, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터에 근거해, 세계의 소아용 관류 시장에 있어서의 주요 기업 프로파일을 제공합니다.
• 이 보고서로부터의 인사이트는 마케팅 담당자나 기업의 경영진이, 장래의 제품 발매, 유형 업, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시하는 것을 가능하게 합니다.
• 세계의 소아용 관류 시장 보고서는 투자자, 공급자, 제품 제조업체, 유통업체, 신규 참가자, 재무 애널리스트 등, 이 업계의 다양한 이해 관계자를 대상으로 하고 있습니다.
• 이해관계자는 세계의 소아용 관류 시장의 분석에 사용되는 다양한 전략 매트릭스를 통해, 의사 결정이 용이하게 됩니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• PORTER 분석
• 합병과 인수 시나리오

제4장 세계 소아용 관류 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 소아용 관류 시장, 제품 유형별, 2020-2032년

• 소아용 캐뉼라
• 원심 혈액 펌프
• 소아 동맥라인
• 막형 인공폐
• 체외 순환 회로
• 기타

제6장 세계의 소아용 관류 시장, 용도별, 2020-2032년

• 심장혈관 수술
• 호흡기계 용도
• 체외막형 인공폐
• 심폐 우회
• 장기 관류와 보존
• 장기 이식
• 기타

제7장 세계의 소아용 관류 시장, 최종 사용자별, 2020-2032년

• 병원
• 전문 클리닉
• 외래수술센터(ASC)
• 기타

제8장 세계의 소아용 관류 시장, 지역별, 2020-2032년

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동
• 아프리카

제9장 경쟁 구도

• Medtronic
• GE Healthcare
• LivaNova, PLC.
• Getinge
• Braile Biomedica
• XENIOS AG
• BL Lifesciences
• Terumo Corporation
• 3M
• Koninklijke Philips NV
• EUROSETS
• Merck KGaA
• Stryker
• Cardinal Health
• Nonin
• Sorin Group USA, Inc.

제10장 섹션

• 조사 방법
• 출판사에 대해

JHS

영문 목차

영문목차

Global Pediatric Perfusion Market is estimated to be valued at USD 575.3 Mn in 2025 and is expected to reach USD 842.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 575.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.60%	2032 Value Projection:	USD 842.5 Mn

Pediatric perfusion is the delivery of blood through the circulatory system in children undergoing cardiopulmonary bypass (CPB) during open heart surgery. CPB involves diverting the patient's blood circulation through a heart-lung machine to maintain circulation and lung gas exchange while the heart is stopped during specific parts of the surgical repair. Pediatric perfusion requires specialized equipment, techniques, and skills to handle the anatomical and physiological differences between adult and pediatric patients. Over the past few decades, procedural success rates have significantly improved due to advancements in perfusion technologies, circuit design modifications, and innovations in surgical techniques tailored for children. However, congenital heart defects continue to be one of the major causes of infant mortality worldwide.

Market Dynamics:

The global pediatric perfusion market is experiencing growth primarily due to the increasing incidence of congenital heart diseases (CHD), a condition affecting nearly 1% of live births according to World Helath Organization (WHO) estimates. Improved diagnostic techniques have led to the early identification of CHD, which, coupled with advancements in pediatric cardiac surgical procedures, has improved survival rates and outcomes. Consequently, this has elevated the number of children who can benefit from pediatric cardiac surgeries and, by extension, pediatric perfusion services.

Pediatric perfusion involves the use of a heart-lung machine to support the child's cardiopulmonary functions during cardiac surgery. As more newborns and infants are diagnosed with CHD and undergo corrective or palliative surgeries, the demand for specialized perfusion equipment has grown. The surgical advancements have allowed for complex cardiac interventions to be performed at earlier stages of life, extending the longevity and quality of life of pediatric CHD patients.

However, the pediatric perfusion market does face challenges. The high cost of pediatric cardiac surgeries can be a significant financial burden for healthcare systems and families, particularly in regions without comprehensive health insurance coverage. Moreover, pediatric perfusion requires specific expertise, and there is a recognized gap in the availability of trained pediatric perfusionists. Another challenge is the increasing focus on off-pump surgical procedures, which can limit the market for perfusion equipment. These surgeries, performed without stopping the heart, may not require a heart-lung machine, thereby decreasing the demand for perfusion services.

Despite these challenges, there are substantial opportunities in the pediatric perfusion market, particularly in the innovation and development of miniaturized perfusion equipment. These devices are better suited for the physiological needs of neonates and infants, offering more precise control and reduced complications. This represents a significant advancement in pediatric cardiac care, offering an attractive opportunity for players in the market. There is also potential for growth in emerging markets, where healthcare infrastructure is expanding, and access to pediatric cardiac care is improving. The burgeoning demand for healthcare services in these regions can stimulate market expansion.

In summary, as medical advancements continue, the global pediatric perfusion market is well-positioned for growth, provided that challenges around costs, training, and technology are strategically addressed. Manufacturers and healthcare providers can capitalize on these opportunities by investing in specialized, cost-effective, and technologically advanced perfusion systems designed for pediatric care.

Key Features of the Study:

• This report provides an in-depth analysis of the global pediatric perfusion market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032, considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pediatric perfusion market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic, GE Healthcare, LivaNova, PLC., Getinge, Braile Biomedica, XENIOS AG, BL Lifesciences, Terumo Corporation, 3M, Koninklijke Philips N.V., EUROSETS, Merck KGaA, Stryker, Cardinal Health, Nonin, and Sorin Group USA, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pediatric perfusion market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric perfusion market

Detailed Segmentation:

• By Product Type:
  • Pediatric Cannulas
  • Centrifugal Blood Pumps
  • Pediatric Arterial Lines
  • Membrane Oxygenators
  • Extracorporeal Circuits
  • Others
• By Application
  • Cardiovascular Surgery
  • Respiratory Applications
  • Extracorporeal Membrane Oxygenation
  • Cardiopulmonary Bypass
  • Organ Perfusion and Preservation
  • Organ Transplantation
  • Others
• By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Medtronic
  • GE Healthcare
  • LivaNova, PLC.
  • Getinge
  • Braile Biomedica
  • XENIOS AG
  • BL Lifesciences
  • Terumo Corporation
  • 3M
  • Koninklijke Philips N.V.
  • EUROSETS
  • Merck KGaA
  • Stryker
  • Cardinal Health
  • Nonin
  • Sorin Group USA, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Pediatric Perfusion Market, By Product Type
  • Pediatric Perfusion Market, By Application
  • Pediatric Perfusion Market, By End User
  • Pediatric Perfusion Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • The increasing incidence of cardiovascular diseases (CVDs) in the pediatric population
  • Increasing government initiatives and funding
  • The emergence of new technologies in pediatric perfusion
  • Technological advancements
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Pediatric Perfusion Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Pediatric Perfusion Market, By Product Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pediatric Cannulas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Centrifugal Blood Pumps
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Pediatric Arterial Lines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Membrane Oxygenators
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Extracorporeal Circuits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Pediatric Perfusion Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Cardiovascular Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Respiratory Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Extracorporeal Membrane Oxygenation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Cardiopulmonary Bypass
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Organ Perfusion and Preservation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Organ Transplantation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Pediatric Perfusion Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Pediatric Perfusion Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Medtronic
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE Healthcare
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• LivaNova, PLC.
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Getinge
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Braile Biomedica
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• XENIOS AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BL Lifesciences
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• 3M
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Koninklijke Philips N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• EUROSETS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Stryker
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cardinal Health
• Nonin
• Sorin Group USA, Inc.
• Analyst Views

10. Section

• Research Methodology
• About us

관련자료